Pricing Log in Create free account

Alterity Therapeutics Limited - Sponsored ADR (ATHE) vs Gain Therapeutics, Inc. (GANX)

Alterity Therapeutics Limited - Sponsored ADR and Gain Therapeutics, Inc. are both Biotechnology companies. Alterity Therapeutics Limited - Sponsored ADR and Gain Therapeutics, Inc. are of similar size ($42.4M and $41.9M). Across the 9 metrics below, Alterity Therapeutics Limited - Sponsored ADR leads on 6 and Gain Therapeutics, Inc. on 3.

Valuation

Metric ATHE GANX Biotechnology median
P/E n/m n/m 10.60
P/S — 219.56 9.40
P/B n/m 3.80 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.94 n/m 0.66
EV/Sales n/m 154.32 9.02
Earnings yield 0.00% (50.00%) (32.88%)
Free cash flow yield 0.00% (44.25%) (23.13%)

Profitability

Metric ATHE GANX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (268.30%) (51.96%)
Return on assets 0.00% (159.22%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATHE GANX Biotechnology median
Revenue growth (TTM) — 18.36% 6.76%
EPS growth (last fiscal year) (22.97%) 31.46% 29.88%
Revenue growth, 5-year CAGR (1.15%) 21.79% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATHE GANX Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 14.52 4.36 4.97
Net debt to EBITDA 1.32 1.10 1.01

Dividend

Metric ATHE GANX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATHE GANX Biotechnology median
Market cap 42.40m 41.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack